1.
Chemotherapy
; 27 Suppl 1: 100-3, 1981.
Article
in English
| MEDLINE
| ID: mdl-7249792
ABSTRACT
Rocephin (Ro 13-9904, ceftriaxone) is a new injectable 3d generation cephalosporin characterised by a high intrinsic activity, a high resistance to beta-lactamases and a half-life of 8 h which is 4-10 times as long as the half-lives of the other cephalosporins. We administered Rocephin intravenously at a dosage of 2 x 1 g/day in 23 cases of septicaemia confirmed by positive blood cultures. The results achieved were good in 21 cases (cure of the infection episode), fair in 1 case (need to supplement Rocephin with ampicillin) and poor in 1 case of septicaemia due to resistant enterococci. The clinical and biological tolerance was excellent, and administration was particularly easy.
Subject(s)
Cephalosporins/therapeutic use , Sepsis/drug therapy , Ceftriaxone , Humans , Male , Middle Aged
2.
Acta Urol Belg
; 48(2): 311-6, 1980 Apr.
Article
in French
| MEDLINE
| ID: mdl-6893895